Donor Interview & Verification Flashcards

Under 49 CFR Part 40, if an MRO cannot reach a donor within 24 hours of a non-negative laboratory result, what is the MRO's next required action?

Answer: Contact the DER to ensure the employee calls the MRO within 72 hours

Per §40.131, when the MRO cannot reach the employee within 24 hours, the MRO must contact the DER so the DER can ensure the employee contacts the MRO within 72 hours.

What is the primary purpose of the MRO's interview with a donor following a non-negative drug test result?

Answer: To determine whether a legitimate medical explanation accounts for the result

The MRO interviews the donor to evaluate whether a legitimate medical explanation, such as a valid prescription, accounts for the non-negative laboratory result before reporting to the employer.

Under DOT regulations, how must the MRO conduct the verification interview with the donor?

Answer: By telephone or in person, on a confidential basis

Per 49 CFR §40.131, the MRO must contact the employee directly and confidentially by telephone or in person to discuss the test result.

When verifying a claimed prescription during a donor interview, the MRO should:

Answer: Contact the prescribing physician or dispensing pharmacy directly to confirm the prescription

The MRO must independently verify the prescription by directly contacting the prescribing physician or dispensing pharmacy, rather than relying solely on the donor's statement.

If a donor fails to contact the MRO within the 72-hour window established by the DER, the MRO should:

Answer: Report the verified result to the DER based on the laboratory findings

If the employee does not contact the MRO within the 72-hour window, the MRO may report the result to the DER based on laboratory findings, since the employee was given a reasonable opportunity to provide an explanation.

A donor presents a valid prescription for amphetamines during the MRO interview. The MRO's next step should be to:

Answer: Evaluate whether the prescribed medication use is consistent with safe performance of safety-sensitive duties

Even with a valid prescription, the MRO must evaluate whether the medication could impair the donor's ability to safely perform safety-sensitive functions before determining the verified result.

Which of the following best describes the MRO's obligation regarding confidentiality during the donor interview process?

Answer: The MRO must keep the interview confidential and only disclose verified results as required by regulation

The MRO must maintain confidentiality throughout the interview process, disclosing only the verified result and required information to authorized parties as specified by 49 CFR Part 40.